The phosphatidylserine market is expected to grow more into North America and European regions due to increasing demands for functional foods and dietary supplements. According to Future Market Insights, the phosphatidylserine market stands at a market value of USD 169.5 Mn in 2022 and is expected to grow at a CAGR of 5.1% to USD 232.5 Mn by 2032.
| Phosphatidylserine Market Size Value in 2022 | USD ~169.5 Mn |
| Phosphatidylserine Market Forecast Value in 2032 | USD ~232.5 Mn |
| Global Growth Rate (2022 to 2032) | ~5.1% CAGR |
| Forecast Period | 2022-2032 |
The expansion of the phosphatidylserine market is being hampered by a very complex production process and restricted utilisation. However, as people become more health-conscious, eating healthy is becoming more popular in Western countries like the United States, Canada, the United Kingdom, Germany, and others. To stay fit and healthy, people use dietary supplements. Phosphatidylserine supplements have a number of health advantages.
Furthermore, to appeal to health-conscious consumers, leading players in the phosphatidylserine supplement market are producing products that are gluten-free, salt-free, sugar-free, starch-free, and fish-free, among other things. Over the projected period of 2022-2032, the phosphatidylserine market is expected to grow at a healthy rate.
The GRAS certification provided by the US Food and Drug Administration is one of the supportive factors for the increased use of phosphatidylserine in dietary supplements as well as expanded employment of phosphatidylserine in other industries. Manufacturers have been urged to include phosphatidylserine into new goods as a result of the funding.
In addition, the FDA authorized phosphatidylserine’s health claim for improving memory and cognitive impairment in 2003. Phosphatidylserine has been introduced into medicinal foods as a result of this permission, particularly for memory-related diseases like Alzheimer’s disease and dementia.
Get Sample of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8959
Key Takeaways from Market Study
- A large portion of dietary supplement users in the United States take supplements for health and wellbeing reasons. In the worldwide phosphatidylserine market, the dietary supplements sub-segment is estimated to account for a significant portion of the end use segment.
- Phosphatidylserine is now used in a minor amount in the cosmetics business, although this is projected to change due to rising research and development spending. The US Food and Drug Administration’s approval and grant are functioning as a stimulus for the worldwide phosphatidylserine market.
- In terms of end use, the Functional Foods segment dominated in 2019. This is due to factors such as an increase in major companies’ investment, an increase in people’s health consciousness, an increase in the demand for phosphatidylserine in functional foods, an increase in people’s disposable income, and an increase in healthier product launches based on customer needs.
“Phosphatidylserine is thought to play a crucial role in the treatment of brain illnesses because it is vital overall good brain health. Phosphatidylserine producers are coming out with more creative products based on its many health benefits, which have a variety of applications in the pharmaceutical business and nutritional supplements.” says a Future Market Insights analyst.
Get a Customized Scope to Match Your Need Ask an Expert@
https://www.futuremarketinsights.com/ask-question/rep-gb-8959
Competitive Landscape
Players in the Phosphatidylserine Market use a variety of methods, including product launches, mergers and acquisitions, joint ventures, and geographic expansion. These manufacturers also participate in various exhibitions and events across the globe to increase the awareness of their products.
- PS-PA Synergy is a patented phosphatidylserine and phosphatidic acid compound that Jarrow Formulas Inc launched in 2015 to boost the stress response under psychological situations.
- Lipogen Products Ltd and Xenesta signed a marketing agreement in 2016 for Lipogen PSPA, a high-quality, vegan-friendly blend of phosphatidylserine and phosphatidic acid.
Some of the leading companies offering phosphatidylserine are Lonza AG, Enzymotec Ltd, Lipogen Products Ltd., Doosan Corporation, Novastell, Nagase ChemteX Corporation, Bontac Bio-engineering (Shenzhen) Co. Ltd., ECA Healthcare, Inc., Lipoid GmbH, and Chemi Nutra LLC.
Get More Valuable Insights
Future Market Insights, in its new offering, provides an unbiased analysis of the phosphatidylserine market presenting historical demand data (2017-2021) and forecast statistics for the period from 2022-2032.
Global Phosphatidylserine Market: Segmentation
By Form:
- Powder
- Liquid
By End Use:
- Functional Foods
- Dietary Supplements & Nutraceuticals
- Cosmetics & Personal Care
By Grade:
- Food Grade
- Pharmaceutical Grade
By Nature:
- Organic
- Conventional
By Source:
- Plant Source
- Soybean
- Sunflower
- Others (Cabbage etc.)
- Animal-derived
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Middle East & Africa
- Oceania
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers, Dubai
United Arab Emirates